Report of a Roundtable Event on ‘Data Protection Regulation

Keeping Health Research Alive in the EU (17 September 2013, Brussels) hosted by MEP Nessa Childers and organised by Science Europe, the Wellcome Trust, the European Alliance for Personalised Medicine, and FEAM

07 / 11 / 2013

FEAM’s Spring Conference 2013

EU regulatory issues: Marita Kinsella (clinical trials) - Billy Hawkes (data protection) - Luke Clancy (tobacco products)

07 / 10 / 2013

Report of FEAM’s Spring Conference 2013

Hosted by the Irish Academy of Medical Sciences at the Royal College of Surgeons in Ireland, Dublin

07 / 10 / 2013

FEAM Working Group

30 / 09 / 2013

FEAM’s response to the EMA’s public consultation on its draft policy on publication and access to clinical-trial data

30 / 09 / 2013

Joint briefing – Roundtable Event on Data Protection Regulation: Keeping Health Research Alive in the EU

Roundtable event at the European Parliament, Brussels hosted by MEP Nessa Childers and organised by Science Europe, the Wellcome Trust, the European Alliance for Personalised Medicine, and FEAM

17 / 09 / 2013

Predictive genetic testing for complex diseases: a public health perspective

C. Marzuillo, C. De Vito, E. D'Andrea, A. Rosso; P. Villari; QJM (2014) 107 (2): 93-97. doi: 10.1093/qjmed/hct190 First published online: September 17, 2013

17 / 09 / 2013

FEAM’s Spring Conference 2013

Future of Clinical Research: Karim Berkouk (EC) - Sir Michael Rawlins (UK) - Ebhlin Mulroe (IPPOSI) - Cyril Höschl (Czech Republic) - Juan Tamargo (Spain) - Sir Peter Lachmann (UK) - David Smith (Ireland) - Detlev Ganten (IAMP)

07 / 09 / 2013

Academic, hospital and charity sectors’ comments on amendments adopted by the European Parliament’s ENVI committee on the Clinical Trials Regulation

13 / 08 / 2013

Reforming the EU environment for clinical trials: what are the challenges?

R. Fears; H.E. Blum; D. Kelleher; F. Meunier; R. Souhami, QJM 2013; doi: 10.1093/qjmed/hct149

27 / 07 / 2013

A derogation for medical resonance imaging (MRI)

is approved by the European Parliament and the European Council on the revised EU Physical Agents Directive 2004/40/EC (press release)

25 / 07 / 2013

Comments from EASAC and FEAM on the In-vitro Diagnostic Medical Devices Regulation

25 / 05 / 2013

Proposal for an EU Regulation on Clinical Trials – A joint statement from non-commercial and commercial organisations

25 / 02 / 2013

Joint FEAM/Wellcome Trust proposed amendments

25 / 02 / 2013

Joint FEAM/Wellcome Trust briefing on data protection and proposed amendments

25 / 02 / 2013

Direct‐to‐Consumer Genetic Testing for Health‐Related Purposes in the European Union

Summary report from a meeting organised by EASAC, FEAM and STOA in the European Parliament on 3 December 2012

30 / 01 / 2013

Joint statement of the Healthcare Coalition on Data Protection

And press releasePress release

29 / 01 / 2013

Summary of the FEAM statement on the Data Protection Regulation and proposed amendments to the EC proposed Regulation

25 / 11 / 2012

The perspective of EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes

European Journal of Human Genetics,

21 / 11 / 2012

Summary of the report on Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

25 / 08 / 2012

Direct-to-consumer genetic testing

The Lancet, Volume 380, Issue 9837, Page 76, 14 July 2012.

25 / 07 / 2012

Summary of FEAM Madrid conference on Ageing

4 May 2012, Spanish Royal National Academy of Medicine

30 / 06 / 2012

Direct-to-consumer genetic testing for health-related purposes in the European Union: the view from EASAC and FEAM

Report

30 / 06 / 2012

Summary of session on ageing

(FEAM Madrid Spring Conference 4-5 May 2012)

25 / 06 / 2012

FEAM statement on the data protection regulation

25 / 06 / 2012